<DOC>
	<DOCNO>NCT02056717</DOCNO>
	<brief_summary>The primary purpose study investigate effect dexamethasone inflammatory reaction uterine artery embolization . The secondary purpose study investigate effect dexamethasone postembolization syndrome ( severe pain , nasea vomit ) .</brief_summary>
	<brief_title>Use Dexamethasone Uterine Artery Embolization</brief_title>
	<detailed_description />
	<mesh_term>Adenomyosis</mesh_term>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Uterine artery embolization due multiple myoma adenomyosis Diabetic mellitus Steroid administration Liver kidney dysfuntion High baseline CRP leukocytosis ( &gt; 11,000/Î¼L ) Drug allergy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>